Table 1. Antimicrobial drug resistance results for ST1478 versus non-ST1478 isolates of vancoymicin-resistant enterococci, Canada, 2013–2018*.
| Antimicrobial drug | % ST1478, n = 115 | % Non-ST1478, n = 493 | p value |
|---|---|---|---|
| Ampicillin | 100.0 | 100.0 | 1 |
| Chloramphenicol | 10.4 | 1 | 0.0001 |
| Ciprofloxacin | 100.0 | 100.0 | 1 |
| Daptomycin | 13.0 | 3.9 | 0.0014 |
| Erythromycin | 100.0 | 92.1 | 0.6068 |
| HL gentamicin | 80.0 | 13.6 | 0.0001 |
| Levfloxacin | 100.0 | 99.6 | 1 |
| Linezolid | 1.7 | 0.4 | 0.1669 |
| Nitrofurantoin | 16.5 | 35.9 | 0.002 |
| Penicillin | 100.0 | 100.0 | 1 |
| Quinupristin/dalfopristin | 0.9 | 8.5 | 0.0032 |
| Rifampin | 95.7 | 90.1 | 0.7104 |
| HL streptomycin | 15.7 | 39.8 | 0.0002 |
| Tetracycline | 91.3 | 46.0 | 0.0001 |
| Tigecycline | 0.9 | 0.4 | 0.4776 |
| Vancomycin | 100.0 | 97.2 | 0.8835 |
*HL, high level; ST, sequence type.